Interface Biologics Announces $1 Million Investment By Ontario’s Investment Accelerator Fund – Life Sciences
Toronto, Canada, December 6, 2011 – For Immediate Release
Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, announces a $1 million investment ...